Direct cost differences of severe sepsis between survivors and non-survivors on day 1 of intensive care admission;A súlyos szepszis kezelésének elso napi költsége az intenzív osztályon a gyógyult és a meghalt betegek összehasonlításában

Orvosi Hetilap

Volumn 148, Issue 39, 2007, Pages 1851-1856

  Csomós, Ákos ^a   Szentkereszty, Zoltán ^b   Fülesdi, Béla ^c  

^a II sz Sebeszeti Klinika   (Hungary)

^b Kenezy Korhaz Rendelointezet   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cost of treatment; Intensive care; Severe sepsis

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; COLLOID; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; DISPOSABLE EQUIPMENT; DRUG COST; FLUID THERAPY; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; HUNGARY; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; RADIOLOGY; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; SEPSIS; SURVIVOR;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BLOOD COMPONENT TRANSFUSION; COSTS AND COST ANALYSIS; FEMALE; HOSPITAL MORTALITY; HUMANS; HUNGARY; INTENSIVE CARE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MEDICAL RECORDS; MIDDLE AGED; NURSING RECORDS; PATIENT ADMISSION; RETROSPECTIVE STUDIES; SEPSIS; SURVIVORS;

EID: 35348870411     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.28055     Document Type: Article

References (17)

1. Brun-Buisson, C., Doyon, F., Carlet, J. és mtsai: Incidence, risk factors and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units. JAMA, 1995, 274, 968-974.
2. Levy, M. M., Fink, M. P., Marshall, J. C. és mtsai: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Int. Care Med., 2003, 29, 530-538.
3. Burchardi, H., Schneider, H.: Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy. Pharmacoeconomics, 2004, 22, 793-813.
4. Csomós Á., Hoffer G., Fülesdi B. és mtsa: A súlyos szepszis gyakorisága és kezelésének költsége az intenzív osztályon. Orv. Hetil., 2005, 146, 1543-1547.
5. Edbrooke, D. L., Hibbert, C. L., Ridley, S. és mtsai: The development of a method for comparative costing of individual intensive care units. Intensive Care Working Group on Costs. Anaesthesia, 1999, 54, 110-120.
6. Bone, R. C., Balk, R. A., Cerra, F. B. és mtsai: Definitions for sepsis and organ failuire and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101, 1664-1655.
7. Drummond, M., O'Brien, B., Stoddart, G. és mtsa: Methods for the evaluation of health care programs. Oxford: Oxford University Press, 1997, 240-260.
8. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J. és mtsai: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome and associated costs of care. Crit. Care Med., 2001, 29, 1303-1310.
9. Alberti C., Brun-Buisson, C., Burchardi, H. és mtsai: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Int. Care Med., 2002, 28, 108-121.
10. Bogár L., Gondos T., Molnár Zs. és mtsa: A súlyos szepszis és a szeptikus shock kezelésének szakmal irányelvei. Aneszteziológiai és Intenzív Terápiás Útmutató, Medition Kiadó, Budapest, 2003, 145-193.
11. Moerer, O., Schmid, A., Hofmann, M. és mtsai: Direct cost of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Int. Care Med., 2002, 28, 1440-1446.
12. Csomós Á., Janecskó M., Edbrooke, D. L.: Comparative costing analysis of intensive care services between Hungary and the United Kingdom. Int. Care Med., 2005, 31, 1280-1283.
13. Guidet, B. R., Harari, A., Hodée, C.: Cost assessment of 21 intensive care units in the Paris area. Int. Care Med., 2003, 29(Suppl. 1.), A522.
14. Prien, T., Singbartl, K.: Is there a means for cost reduction in intensive care fluid therapy without a loss of quality? Der Anaesthetist, 1998, 47, 395-399.
15. Dellinger, R. P., Carlet, J. M., Masur, H. és mtsai: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med., 2004, 32, 858-873.
16. Edbrooke, D. L., Ridley, S. A., Hibbert, C. L. és mtsa: Variations in expenditure between adult general intensive care units in the UK. Anaesthesia, 2001, 56, 208-216.
17. Organisation for Economic Co-operation and Development database, http://www.oecd.org/statsportal/ (letöltve 2006. szept. 12.)